Global Pregnancy Testing Market - 2025 -2033
Pregnancy Testing Market Size and Growth
The global pregnancy testing market reached US$ 1.63 billion in 2023, with a rise to US$ 1.72 billion in 2024, and is expected to reach US$ 2.88 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025–2033. The pregnancy testing market is experiencing steady growth, driven by increasing awareness around reproductive health, and the growing demand for convenient at-home diagnostic solutions. Advancements in testing technologies have enhanced accuracy, user experience, and accessibility. Additionally, the global shift toward proactive personal healthcare and the availability of over-the-counter pregnancy tests through online and retail channels have further fueled market expansion.
Key Market Trends & Insights
Driver: Rising Awareness of Reproductive Health
The increasing awareness of reproductive health is playing a pivotal role in driving the growth of the pregnancy testing market. As education on reproductive wellness expands globally, more individuals are recognizing the importance of early pregnancy detection for both maternal and fetal health outcomes. This growing knowledge base encourages timely pregnancy testing, enabling women to seek appropriate prenatal care and make informed decisions.
Additionally, public health initiatives and digital information platforms have contributed to reducing social stigma surrounding reproductive health, particularly in emerging economies. This has translated into higher acceptance and adoption of home-based pregnancy testing kits, which offer convenience, privacy, and affordability.
Furthermore, the emphasis on reproductive planning and self-care is motivating consumers to actively monitor their fertility status, thereby boosting demand for reliable and easy-to-use pregnancy tests. Healthcare providers and policymakers’ efforts to promote reproductive health education further support market expansion by increasing consumer awareness and engagement. Overall, the rising focus on reproductive health awareness is expected to sustain strong growth in the pregnancy testing market by driving consumer adoption and encouraging innovation.
Restraint: False Positives/Negatives and Test Accuracy Concerns
False positives, false negatives, and test accuracy concerns can significantly hamper the pregnancy testing market by undermining consumer trust and confidence. False positives can cause emotional distress and lead to legal liabilities, while false negatives may delay crucial prenatal care, impacting health outcomes. These inaccuracies damage the reputation of brands and the overall market, prompting customers to seek more reliable alternatives or clinical testing. Additionally, accuracy issues can increase regulatory scrutiny and operational costs due to returns and complaints. As a result, consumer demand may decline, and companies might face challenges in innovation and maintaining market share, ultimately slowing market growth and profitability.
Market Segmentation Analysis
The pregnancy testing market is segmented by product type, test type, distribution channel, end-user, and region.
Product Type-The line indicator kits segment is estimated to have 39.7% of the pregnancy testing market share.
The line indicator kits segment is poised to dominate the pregnancy testing market due to their affordability, simplicity, and widespread availability. These kits, which include strips, cassettes, and mid-stream devices, utilize lateral flow immunoassay technology to detect the presence of human chorionic gonadotropin (hCG) hormone in urine. The results are indicated by one or two colored lines, making them easy to interpret without requiring technical expertise.
The line indicator segment accounted for approximately 48.6% of the pregnancy test kit market in 2024. Their affordability ensures accessibility across a broad spectrum of income groups, especially in low- and middle-income countries. For instance, in densely populated regions across Asia, Latin America, and Africa, low-cost healthcare solutions are in high demand, and line indicator kits perfectly align with this need.
They offer several benefits, such as cost-efficiency, self-care, and self-diagnosis of pregnancy. Moreover, companies are actively involved in new pregnancy testing product launches, which increase the availability of products, driving the market growth.
Market Geographical Share
The North America pregnancy testing market was valued at 38.40% market share in 2024
North America holds a commanding position in the global pregnancy testing market, accounting for approximately 38.4% of the market share as of 2023. This dominance is driven by several key factors, including high consumer awareness about reproductive health, well-established healthcare infrastructure, and the widespread availability of advanced pregnancy testing products. The region benefits from a strong network of pharmacies, retail outlets, and online platforms that make pregnancy tests highly accessible to consumers.
Moreover, North America has witnessed the rapid adoption of cutting-edge digital and smartphone-enabled pregnancy tests, which offer enhanced accuracy and user-friendly interfaces, appealing to tech-savvy and health-conscious consumers alike. The presence of major market players and continuous investment in research and development further bolsters the region’s leadership, enabling the introduction of innovative products that meet evolving consumer demands. For instance, in November 2024, Myriad Genetics, Inc. announced expanded retail availability of its SneakPeek prenatal test. Now accessible over-the-counter in more than 8,800 retail locations across the U.S., including Walmart stores, SneakPeek becomes the first gender test of its kind available on the shelf at major retailers.
Additionally, growing emphasis on women’s health, increased awareness of early pregnancy detection, and supportive regulatory frameworks contribute to sustaining North America’s position as the largest and most mature market globally.
The Asia-Pacific pregnancy testing market was valued at 19.20% market share in 2024
Asia-Pacific is emerging as the fastest-growing region in the pregnancy testing market, driven by a convergence of demographic, economic, and healthcare factors. The region boasts the world’s largest reproductive-age female population, creating a vast and expanding customer base for pregnancy testing products. Rising awareness of reproductive and maternal health, coupled with improvements in healthcare infrastructure, is facilitating greater adoption of pregnancy tests, particularly in urban and semi-urban areas.
Furthermore, the rapid expansion of e-commerce platforms is playing a crucial role in overcoming traditional distribution challenges, enabling convenient and discreet access to pregnancy tests. Governments and non-profit organizations are actively promoting maternal health awareness, further fueling demand. The region is also witnessing significant innovation, with manufacturers introducing affordable, easy-to-use products tailored to local consumer preferences. As a result, Asia-Pacific represents a highly attractive and dynamic market, offering substantial growth opportunities for both established players and new entrants eager to capitalize on rising demand across diverse and populous countries such as China, India, Japan, and Southeast Asian nations.
Market Competitive Landscape
The major players in the pregnancy testing market include Procter & Gamble, Abbott, Biosynex SA, NG Biotech, BIOM?RIEUX, EKF Diagnostics Holdings plc, Atlas Medical GmbH, QuidelOrtho Corporation, Cardinal Health, among others.
Key Developments:
The global pregnancy testing market reached US$ 1.63 billion in 2023, with a rise to US$ 1.72 billion in 2024, and is expected to reach US$ 2.88 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025–2033. The pregnancy testing market is experiencing steady growth, driven by increasing awareness around reproductive health, and the growing demand for convenient at-home diagnostic solutions. Advancements in testing technologies have enhanced accuracy, user experience, and accessibility. Additionally, the global shift toward proactive personal healthcare and the availability of over-the-counter pregnancy tests through online and retail channels have further fueled market expansion.
Key Market Trends & Insights
- North America accounted for approximately 38.4% of the pregnancy testing market in 2024 and is expected to maintain its leading position throughout the forecast period. This dominance is driven by high consumer awareness around reproductive health, well-established healthcare infrastructure, widespread availability of over-the-counter pregnancy tests, and rapid adoption of advanced digital and smart pregnancy testing technologies.
- Asia Pacific is projected to be the fastest-growing region, fueled by expanding healthcare access, rising reproductive-age female population, increasing awareness of maternal health, and growing adoption of convenient at-home diagnostic solutions. Economic development and growing e-commerce penetration further accelerate market growth in this region.
- Line Indicator Kits remain the dominant product segment, favored for their affordability, ease of use, and wide availability across retail and clinical channels.
- 2024 Market Size: US$ 1.72 Billion
- 2033 Projected Market Size: US$ 2.88 Billion
- CAGR (2025–2033): 6.0%
- North America: Largest market in 2024
- Asia Pacific: Fastest-growing market
Driver: Rising Awareness of Reproductive Health
The increasing awareness of reproductive health is playing a pivotal role in driving the growth of the pregnancy testing market. As education on reproductive wellness expands globally, more individuals are recognizing the importance of early pregnancy detection for both maternal and fetal health outcomes. This growing knowledge base encourages timely pregnancy testing, enabling women to seek appropriate prenatal care and make informed decisions.
Additionally, public health initiatives and digital information platforms have contributed to reducing social stigma surrounding reproductive health, particularly in emerging economies. This has translated into higher acceptance and adoption of home-based pregnancy testing kits, which offer convenience, privacy, and affordability.
Furthermore, the emphasis on reproductive planning and self-care is motivating consumers to actively monitor their fertility status, thereby boosting demand for reliable and easy-to-use pregnancy tests. Healthcare providers and policymakers’ efforts to promote reproductive health education further support market expansion by increasing consumer awareness and engagement. Overall, the rising focus on reproductive health awareness is expected to sustain strong growth in the pregnancy testing market by driving consumer adoption and encouraging innovation.
Restraint: False Positives/Negatives and Test Accuracy Concerns
False positives, false negatives, and test accuracy concerns can significantly hamper the pregnancy testing market by undermining consumer trust and confidence. False positives can cause emotional distress and lead to legal liabilities, while false negatives may delay crucial prenatal care, impacting health outcomes. These inaccuracies damage the reputation of brands and the overall market, prompting customers to seek more reliable alternatives or clinical testing. Additionally, accuracy issues can increase regulatory scrutiny and operational costs due to returns and complaints. As a result, consumer demand may decline, and companies might face challenges in innovation and maintaining market share, ultimately slowing market growth and profitability.
Market Segmentation Analysis
The pregnancy testing market is segmented by product type, test type, distribution channel, end-user, and region.
Product Type-The line indicator kits segment is estimated to have 39.7% of the pregnancy testing market share.
The line indicator kits segment is poised to dominate the pregnancy testing market due to their affordability, simplicity, and widespread availability. These kits, which include strips, cassettes, and mid-stream devices, utilize lateral flow immunoassay technology to detect the presence of human chorionic gonadotropin (hCG) hormone in urine. The results are indicated by one or two colored lines, making them easy to interpret without requiring technical expertise.
The line indicator segment accounted for approximately 48.6% of the pregnancy test kit market in 2024. Their affordability ensures accessibility across a broad spectrum of income groups, especially in low- and middle-income countries. For instance, in densely populated regions across Asia, Latin America, and Africa, low-cost healthcare solutions are in high demand, and line indicator kits perfectly align with this need.
They offer several benefits, such as cost-efficiency, self-care, and self-diagnosis of pregnancy. Moreover, companies are actively involved in new pregnancy testing product launches, which increase the availability of products, driving the market growth.
Market Geographical Share
The North America pregnancy testing market was valued at 38.40% market share in 2024
North America holds a commanding position in the global pregnancy testing market, accounting for approximately 38.4% of the market share as of 2023. This dominance is driven by several key factors, including high consumer awareness about reproductive health, well-established healthcare infrastructure, and the widespread availability of advanced pregnancy testing products. The region benefits from a strong network of pharmacies, retail outlets, and online platforms that make pregnancy tests highly accessible to consumers.
Moreover, North America has witnessed the rapid adoption of cutting-edge digital and smartphone-enabled pregnancy tests, which offer enhanced accuracy and user-friendly interfaces, appealing to tech-savvy and health-conscious consumers alike. The presence of major market players and continuous investment in research and development further bolsters the region’s leadership, enabling the introduction of innovative products that meet evolving consumer demands. For instance, in November 2024, Myriad Genetics, Inc. announced expanded retail availability of its SneakPeek prenatal test. Now accessible over-the-counter in more than 8,800 retail locations across the U.S., including Walmart stores, SneakPeek becomes the first gender test of its kind available on the shelf at major retailers.
Additionally, growing emphasis on women’s health, increased awareness of early pregnancy detection, and supportive regulatory frameworks contribute to sustaining North America’s position as the largest and most mature market globally.
The Asia-Pacific pregnancy testing market was valued at 19.20% market share in 2024
Asia-Pacific is emerging as the fastest-growing region in the pregnancy testing market, driven by a convergence of demographic, economic, and healthcare factors. The region boasts the world’s largest reproductive-age female population, creating a vast and expanding customer base for pregnancy testing products. Rising awareness of reproductive and maternal health, coupled with improvements in healthcare infrastructure, is facilitating greater adoption of pregnancy tests, particularly in urban and semi-urban areas.
Furthermore, the rapid expansion of e-commerce platforms is playing a crucial role in overcoming traditional distribution challenges, enabling convenient and discreet access to pregnancy tests. Governments and non-profit organizations are actively promoting maternal health awareness, further fueling demand. The region is also witnessing significant innovation, with manufacturers introducing affordable, easy-to-use products tailored to local consumer preferences. As a result, Asia-Pacific represents a highly attractive and dynamic market, offering substantial growth opportunities for both established players and new entrants eager to capitalize on rising demand across diverse and populous countries such as China, India, Japan, and Southeast Asian nations.
Market Competitive Landscape
The major players in the pregnancy testing market include Procter & Gamble, Abbott, Biosynex SA, NG Biotech, BIOM?RIEUX, EKF Diagnostics Holdings plc, Atlas Medical GmbH, QuidelOrtho Corporation, Cardinal Health, among others.
Key Developments:
- In October 2024, First Response is excited to introduce the Multi Check Pregnancy Test Kit, featuring EasyCup. EasyCup offers a unique combination of a sample collection cup with an integrated test strip, making the testing process more convenient and user-friendly. This design leverages the familiar urine collection experience commonly used in clinical settings, delivering reliable and accurate results with ease.
- In February 2023, Abingdon Health plc announced a new distribution agreement with Salignostics for the launch of Salistick, the UK and Ireland’s first saliva-based pregnancy test.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Test Type
2.5. Snippet by Distribution Channel
2.6. Snippet by End-User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Awareness of Reproductive Health
3.1.1.2. Growing Preference for At-Home Testing
3.1.2. Restraints
3.1.2.1. False Positives/Negatives and Test Accuracy Concerns
3.1.2.2. Competition from Clinical Testing
3.1.3. Opportunity
3.1.3.1. Product Innovation and Diversification
3.1.3.2. Emerging Markets Expansion
3.1.4. Impact Analysis
4. GLOBAL PREGNANCY TESTING MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL PREGNANCY TESTING MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Line Indicator Kits*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. Test Strips
5.2.4. Test Sticks
5.2.5. Others (Cassettes)
5.3. Digital Devices
5.4. Others
6. GLOBAL PREGNANCY TESTING MARKET: BY TEST TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
6.1.2. Market Attractiveness Index, By Test Type
6.2. hCG Urine Test*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. hCG Blood Test
6.4. FSH Urine Test
6.5. LH Urine Test
7. GLOBAL PREGNANCY TESTING MARKET: BY DISTRIBUTION CHANNEL
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Pharmacies/Drugstores*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Online Sales
7.4. Gynecology/ Fertility Clinics
7.5. Supermarkets
7.6. Hypermarkets
8. GLOBAL PREGNANCY TESTING MARKET: BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Home Care*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals
8.4. Others
9. REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Abbott*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. BIOM?RIEUX
11.3. EKF Diagnostics Holdings plc
11.4. Atlas Medical GmbH
11.5. QuidelOrtho Corporation
11.6. Biosynex SA
11.7. NG Biotech
11.8. Cardinal Health
11.9. Thermo Fisher Scientific Inc.
11.10. Procter & Gamble (LIST NOT EXHAUSTIVE)
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Test Type
2.5. Snippet by Distribution Channel
2.6. Snippet by End-User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Awareness of Reproductive Health
3.1.1.2. Growing Preference for At-Home Testing
3.1.2. Restraints
3.1.2.1. False Positives/Negatives and Test Accuracy Concerns
3.1.2.2. Competition from Clinical Testing
3.1.3. Opportunity
3.1.3.1. Product Innovation and Diversification
3.1.3.2. Emerging Markets Expansion
3.1.4. Impact Analysis
4. GLOBAL PREGNANCY TESTING MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL PREGNANCY TESTING MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Line Indicator Kits*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. Test Strips
5.2.4. Test Sticks
5.2.5. Others (Cassettes)
5.3. Digital Devices
5.4. Others
6. GLOBAL PREGNANCY TESTING MARKET: BY TEST TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
6.1.2. Market Attractiveness Index, By Test Type
6.2. hCG Urine Test*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. hCG Blood Test
6.4. FSH Urine Test
6.5. LH Urine Test
7. GLOBAL PREGNANCY TESTING MARKET: BY DISTRIBUTION CHANNEL
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Pharmacies/Drugstores*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Online Sales
7.4. Gynecology/ Fertility Clinics
7.5. Supermarkets
7.6. Hypermarkets
8. GLOBAL PREGNANCY TESTING MARKET: BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Home Care*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals
8.4. Others
9. REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Abbott*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. BIOM?RIEUX
11.3. EKF Diagnostics Holdings plc
11.4. Atlas Medical GmbH
11.5. QuidelOrtho Corporation
11.6. Biosynex SA
11.7. NG Biotech
11.8. Cardinal Health
11.9. Thermo Fisher Scientific Inc.
11.10. Procter & Gamble (LIST NOT EXHAUSTIVE)
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Pregnancy Testing Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Pregnancy Testing Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Pregnancy Testing Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Pregnancy Testing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Pregnancy Testing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Pregnancy Testing Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Pregnancy Testing Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 10 Global Pregnancy Testing Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 12 Global Pregnancy Testing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 14 Global Pregnancy Testing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Pregnancy Testing Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 18 North America Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 19 North America Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 North America Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Europe Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 28 Europe Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 29 Europe Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Europe Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 South America Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 33 South America Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 34 South America Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 35 South America Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Abbott : Overview
Table 42 Abbott : Product Portfolio
Table 43 Abbott : Key Developments
Table 44 BIOM?RIEUX: Overview
Table 45 BIOM?RIEUX: Product Portfolio
Table 46 BIOM?RIEUX: Key Developments
Table 47 EKF Diagnostics Holdings plc: Overview
Table 48 EKF Diagnostics Holdings plc: Product Portfolio
Table 49 EKF Diagnostics Holdings plc: Key Developments
Table 50 Atlas Medical GmbH: Overview
Table 51 Atlas Medical GmbH: Product Portfolio
Table 52 Atlas Medical GmbH: Key Developments
Table 53 QuidelOrtho Corporation: Overview
Table 54 QuidelOrtho Corporation: Product Portfolio
Table 55 QuidelOrtho Corporation: Key Developments
Table 56 Biosynex SA: Overview
Table 57 Biosynex SA: Product Portfolio
Table 58 Biosynex SA: Key Developments
Table 59 NG Biotech: Overview
Table 60 NG Biotech: Product Portfolio
Table 61 NG Biotech: Key Developments
Table 62 Cardinal Health: Overview
Table 63 Cardinal Health: Product Portfolio
Table 64 Cardinal Health: Key Developments
Table 65 Thermo Fisher Scientific Inc.: Overview
Table 66 Thermo Fisher Scientific Inc.: Product Portfolio
Table 67 Thermo Fisher Scientific Inc.: Key Developments
Table 68 Procter & Gamble: Overview
Table 69 Procter & Gamble: Product Portfolio
Table 70 Procter & Gamble: Key Developments
Table 1 Global Pregnancy Testing Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Pregnancy Testing Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Pregnancy Testing Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Pregnancy Testing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Pregnancy Testing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Pregnancy Testing Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Pregnancy Testing Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 10 Global Pregnancy Testing Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 12 Global Pregnancy Testing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 14 Global Pregnancy Testing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Pregnancy Testing Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 18 North America Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 19 North America Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 North America Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Europe Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 28 Europe Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 29 Europe Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Europe Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 South America Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 33 South America Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 34 South America Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 35 South America Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Abbott : Overview
Table 42 Abbott : Product Portfolio
Table 43 Abbott : Key Developments
Table 44 BIOM?RIEUX: Overview
Table 45 BIOM?RIEUX: Product Portfolio
Table 46 BIOM?RIEUX: Key Developments
Table 47 EKF Diagnostics Holdings plc: Overview
Table 48 EKF Diagnostics Holdings plc: Product Portfolio
Table 49 EKF Diagnostics Holdings plc: Key Developments
Table 50 Atlas Medical GmbH: Overview
Table 51 Atlas Medical GmbH: Product Portfolio
Table 52 Atlas Medical GmbH: Key Developments
Table 53 QuidelOrtho Corporation: Overview
Table 54 QuidelOrtho Corporation: Product Portfolio
Table 55 QuidelOrtho Corporation: Key Developments
Table 56 Biosynex SA: Overview
Table 57 Biosynex SA: Product Portfolio
Table 58 Biosynex SA: Key Developments
Table 59 NG Biotech: Overview
Table 60 NG Biotech: Product Portfolio
Table 61 NG Biotech: Key Developments
Table 62 Cardinal Health: Overview
Table 63 Cardinal Health: Product Portfolio
Table 64 Cardinal Health: Key Developments
Table 65 Thermo Fisher Scientific Inc.: Overview
Table 66 Thermo Fisher Scientific Inc.: Product Portfolio
Table 67 Thermo Fisher Scientific Inc.: Key Developments
Table 68 Procter & Gamble: Overview
Table 69 Procter & Gamble: Product Portfolio
Table 70 Procter & Gamble: Key Developments
LIST OF FIGURES
Figure 1 Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 4 Global Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 5 Global Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 6 Global Pregnancy Testing Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Pregnancy Testing Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Line Indicator Kits Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 9 Digital Devices Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 10 Others Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Pregnancy Testing Market Y-o-Y Growth, By Test Type, 2023-2033 (%)
Figure 12 hCG Blood Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 13 hCG Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 14 FSH Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 15 LH Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 16 Global Pregnancy Testing Market Y-o-Y Growth, By Distribution Channel, 2023-2033 (%)
Figure 17 Pharmacies/Drugstores Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 18 Online Sales Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 19 Gynecology/ Fertility Clinics Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 20 Supermarkets Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 21 Hypermarkets Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Pregnancy Testing Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 23 Home Care End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 24 Hospitals End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 25 Others End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 26 Global Pregnancy Testing Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 27 North America Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 28 North America Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 29 North America Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 30 North America Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 31 North America Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 32 North America Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 33 Asia-Pacific Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 34 Asia-Pacific Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 Asia-Pacific Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 36 Asia-Pacific Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 37 Asia-Pacific Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 38 Asia-Pacific Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 39 Europe Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 40 Europe Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 41 Europe Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 42 Europe Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 43 Europe Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 44 Europe Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 45 South America Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 46 South America Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 47 South America Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 48 South America Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 49 South America Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 50 South America Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 51 Middle East and Africa Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 52 Middle East and Africa Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 53 Middle East and Africa Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 54 Middle East and Africa Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 55 Middle East and Africa Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 56 Abbott : Financials
Figure 57 BIOM?RIEUX: Financials
Figure 58 EKF Diagnostics Holdings plc: Financials
Figure 59 Atlas Medical GmbH: Financials
Figure 60 QuidelOrtho Corporation: Financials
Figure 61 Biosynex SA: Financials
Figure 62 NG Biotech: Financials
Figure 63 Cardinal Health: Financials
Figure 64 Thermo Fisher Scientific Inc.: Financials
Figure 65 Procter & Gamble: Financials
Figure 1 Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 4 Global Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 5 Global Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 6 Global Pregnancy Testing Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Pregnancy Testing Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Line Indicator Kits Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 9 Digital Devices Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 10 Others Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Pregnancy Testing Market Y-o-Y Growth, By Test Type, 2023-2033 (%)
Figure 12 hCG Blood Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 13 hCG Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 14 FSH Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 15 LH Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 16 Global Pregnancy Testing Market Y-o-Y Growth, By Distribution Channel, 2023-2033 (%)
Figure 17 Pharmacies/Drugstores Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 18 Online Sales Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 19 Gynecology/ Fertility Clinics Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 20 Supermarkets Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 21 Hypermarkets Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Pregnancy Testing Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 23 Home Care End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 24 Hospitals End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 25 Others End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 26 Global Pregnancy Testing Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 27 North America Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 28 North America Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 29 North America Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 30 North America Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 31 North America Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 32 North America Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 33 Asia-Pacific Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 34 Asia-Pacific Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 Asia-Pacific Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 36 Asia-Pacific Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 37 Asia-Pacific Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 38 Asia-Pacific Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 39 Europe Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 40 Europe Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 41 Europe Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 42 Europe Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 43 Europe Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 44 Europe Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 45 South America Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 46 South America Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 47 South America Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 48 South America Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 49 South America Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 50 South America Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)
Figure 51 Middle East and Africa Pregnancy Testing Market Value, 2022-2033 (US$ Billion)
Figure 52 Middle East and Africa Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)
Figure 53 Middle East and Africa Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)
Figure 54 Middle East and Africa Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)
Figure 55 Middle East and Africa Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)
Figure 56 Abbott : Financials
Figure 57 BIOM?RIEUX: Financials
Figure 58 EKF Diagnostics Holdings plc: Financials
Figure 59 Atlas Medical GmbH: Financials
Figure 60 QuidelOrtho Corporation: Financials
Figure 61 Biosynex SA: Financials
Figure 62 NG Biotech: Financials
Figure 63 Cardinal Health: Financials
Figure 64 Thermo Fisher Scientific Inc.: Financials
Figure 65 Procter & Gamble: Financials
